By InvitationNot Applicable

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.

Spain100 participantsStarted 2025-05-14

Plain-language summary

This is a prospective, observational study at the ICU of Hospital Mútua de Terrassa, running from May to December 2025. The primary goal is to determine the prevalence of sarcopenia in adult patients requiring more than 48 hours of mechanical ventilation. Sarcopenia is assessed using the SARC-F score, impedanciometry, and quadriceps ultrasound. Secondary aims include tracking the development of ICU-Acquired Weakness (ICU-AW) using the MRC score. All data is collected anonymously after obtaining informed consent.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Older than 18 years old. * Expected duration of mechanical ventilation (MV) exceeding 48 hours. Exclusion Criteria: * Refusal to participate. * Mechanical ventilation not exceeding 48 hours. * Do-not-resuscitate (DNR) orders or limitations of therapeutic effort upon admission.

What they're measuring

Prevalence of sarcopenia at the time of ICU admission.

Timeframe: Baseline at admission to ICU

Trial details

NCT IDNCT07303335

SponsorHospital Mutua de Terrassa

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Sarcopenia trials